Nasdaq: $26.24 (-2.96) | AIM: £3.96 (+0)
News & Presentations
Previous Article   |   Next Article
Corporate presentations, Presentations | 28 Nov 2012

Chi-Med/Nestlé Health Science Analyst Conference Call Transcript